Fosfomycin Tromethamine

Fosfomycin Tromethamine

5.7 Moderate risk

Fosfomycin Tromethamine & Bladder transitional cell carcinoma

64.3%

of users reported Bladder transitional cell carcinoma

66.7%

also reported Hospitalization

100.0%

are women

Most common medical consequences

Hospitalization
66.7%
Severe reaction
33.3%

Have you experienced any negative side effects from this medication?

Fosfomycin Tromethamine: general information

Most common side effects (2)

Most commonly affected ages

60 - 69 years
100.0%